A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Heparin Assay (Anti-Xa)-LMWH
Test CodeAlias/See Also
CPT Codes
85520
Preferred Specimen
1 Blue
Minimum Volume
Other Acceptable Specimens
Instructions
Outreach clients should double-spin the blue top plasma, remove the plasma from the RBC button, and freeze in a polypropylene tube.
Transport Container
BLUE/1
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Colorimetric
Setup Schedule
Daily 0600 - 1300
Report Available
Reference Range
SEE REPORT
Clinical Significance
The Anti-Xa Assay is intended for the quantitative determination of the plasma levels of low molecular weight heparin (LMWH) by the measurement of their anti-Xa activity on antithrombin in a competitive system using a synthetic chromogenic substrate.
The normal function of a molecule of factor Xa, as soon as it appears in plasma, is to cleave its natural substrate, Prothrombin, to generate thrombin, the enzyme responsible for the fibrin clot formation. In the presence of heparin, competition occurs between this mechanism and the inhibitory mechanism exerted by the heparin-antithrombin III complex, this inhibition being largely responsible for the action of heparin. The heparin-antithrombin complex is made up from the heparin and the antithrombin (AT) from the patient.
Unfractionated Heparin (UFH) and Low molecular weight heparins (LMWH) are used for the prevention and treatment of thromboembolic diseases. The quantitative determination of plasma UFH and LMWH levels are useful for monitoring treatment efficacy.